Apyx Medical Announces Positive Clinical Study for Renuvion in Body Contouring

summarizeSummary

Apyx Medical announced the publication of a new study showing its Renuvion system significantly improves patient satisfaction and reduces revision rates when used with liposuction.

check_boxKey Events

• Positive Clinical Study Publication

  A new retrospective investigator-initiated study was published, evaluating patient-reported outcomes following liposuction with and without Apyx Medical's Renuvion helium plasma radiofrequency.

• Improved Patient Satisfaction

  Patients treated with Renuvion reported statistically higher satisfaction with abdominal appearance and reduced appearance of excess skin compared to conventional liposuction alone.

• Reduced Revision Rates

  The study demonstrated a more than 50% lower rate of abdominoplasty and significantly lower surgical revision rates in the Renuvion group.

• Comparable Safety Profile

  Complication rates remained similar between the Renuvion group and the group receiving power-assisted liposuction only.

auto_awesomeAnalysis

This publication provides strong clinical validation for Apyx Medical's Renuvion technology, demonstrating improved patient outcomes and reduced need for follow-up procedures in body contouring. The positive data strengthens the product's market position and supports its adoption in a large aesthetic surgery market, reinforcing the company's growth prospects following recent positive financial results and FDA clearance for its AYON system.